Taraxacum officinale extract induces antitumorigenic effects in ovarian carcinoma cell lines

Journal Title: European Journal of Gynaecological Oncology - Year 2019, Vol 40, Issue 1

Abstract

Purpose of Investigation: Patients suffering from ovarian cancer often use mistletoe preparations in combination with Taraxacum officinale (dandelion) extracts as supplementary therapy to conventional medicine. However, scientific data concerning antitumorigenic effects of Taraxacum extracts and co-treatment with mistletoe extracts are insufficient. Materials and Methods: Sensitivity of cancer cell lines towards a Taraxacum extract was determined by cell viability assays. Effects of Taraxacum on cell proliferation, cell cycle distribution, mitochondrial integrity, as well as migration and invasion were investigated in ovarian carcinoma cells (NIH:OVCAR-3 and SKOV-3). Results: Taraxacum extract caused a reduction of cell viability in a panel of adult cancer cell lines (cervical-, colon-, endometrial-, hepatocellular-, lung-, mamma-, ovarian-, pancreatic-, and urinary bladder carcinoma), whereby gynecological tumors were particularly susceptible. Inhibitory effects on cell viability, migration, mitochondrial integrity, and induction of apoptosis were observed in ovarian cancer cells. Combined therapy with mistletoe extracts revealed synergistic effects. Conclusion: This study provides first preclinical data on the antitumorigenic effects of Taraxacum and demonstrates the effectiveness of a combination treatment with mistletoe extracts in ovarian cancer cells.

Authors and Affiliations

K. Menke, M. Schwermer, J. Felenda, C. Beckmann, F. Stintzing, A. Voigt, T. J. Zuzak

Keywords

Related Articles

Taraxacum officinale extract induces antitumorigenic effects in ovarian carcinoma cell lines

Purpose of Investigation: Patients suffering from ovarian cancer often use mistletoe preparations in combination with Taraxacum officinale (dandelion) extracts as supplementary therapy to conventional medicine. However,...

Complementary and alternative medicine. Use and challenges among gynaecological cancer patients in Nigeria: experiences in a tertiary health institution - preliminary results

Background: Cancer patients have keyed into increasing global interest in the use of Complementary and Alternative Medicine (CAM). There are few studies on CAM use among gynaecological cancer patients in our environment....

Risk of cervical cancer and squamous intraepithelial lesions according to human papillomavirus high-risk serotypes detected by qualitative real-time in vitro PCR

Purpose of investigation: To establish the relationship between high-risk human papillomavirus (hrHPV) serotypes and the odds of developing cervical intraepithelial lesions. Material and Methods: Retrospective cohort stu...

Expression of FOXA1 in breast cancer and the significance

Objective: The aim of this study to examine the expression of FOXA1, ER, and PR in breast cancer and investigate the association between FOXA1 expression and clinical parameters. Materials and Methods: One hundred one ca...

Concurrent chemoradiotherapy combined with immunotherapy is superior to traditional concurrent chemoradiotherapy in the treatment of advanced cervical cancer

Purpose of investigation: In advanced cervical cancer, traditional therapy included concurrent chemoradiotherapy (CCRT), pelvic radiotherapy, and brachytherapy. In the last few years, the development of using of immunoth...

Download PDF file
  • EP ID EP663046
  • DOI 10.12892/ejgo4460.2019
  • Views 48
  • Downloads 0

How To Cite

K. Menke, M. Schwermer, J. Felenda, C. Beckmann, F. Stintzing, A. Voigt, T. J. Zuzak (2019). Taraxacum officinale extract induces antitumorigenic effects in ovarian carcinoma cell lines. European Journal of Gynaecological Oncology, 40(1), 106-112. https://europub.co.uk/articles/-A-663046